Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Impact of Enhanced Recovery After Esophagectomy in Patients With Esophageal Cancer.
Sugase T, Kanemura T, Takeoka T, Urakawa S, Sugimura K, Masuike Y, Shinno N, Hara H, Omori T, Kitakaze M, Kubo M, Mukai Y, Sueda T, Hasegawa S, Akita H, Nishimura J, Wada H, Yasui M, Miyata H. Sugase T, et al. Among authors: takeoka t. Anticancer Res. 2023 Sep;43(9):4197-4205. doi: 10.21873/anticanres.16611. Anticancer Res. 2023. PMID: 37648293
The utility of bile juice culture analysis for the management of postoperative infection after pancreaticoduodenectomy.
Asukai K, Akita H, Mukai Y, Mikamori M, Hasegawa S, Fujii Y, Sugase T, Yamamoto M, Takeoka T, Shinno N, Hara H, Kanemura T, Haraguchi N, Nishimura J, Matsuda C, Yasui M, Omori T, Miyata H, Ohue M, Sakon M, Wada H, Takahashi H. Asukai K, et al. Among authors: takeoka t. Surgery. 2023 Apr;173(4):1039-1044. doi: 10.1016/j.surg.2022.11.021. Epub 2022 Dec 20. Surgery. 2023. PMID: 36549976
DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer.
Hasegawa S, Takahashi H, Akita H, Mukai Y, Mikamori M, Asukai K, Yamada D, Wada H, Fujii Y, Sugase T, Yamamoto M, Takeoka T, Shinno N, Hara H, Kanemura T, Haraguchi N, Nishimura J, Matsuda C, Yasui M, Omori T, Miyata H, Ohue M, Ishikawa O, Sakon M. Hasegawa S, et al. Among authors: takeoka t. BMC Cancer. 2023 Jan 18;23(1):63. doi: 10.1186/s12885-023-10512-2. BMC Cancer. 2023. PMID: 36653747 Free PMC article.
Patterns of Recurrence and Long-Term Survival of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Locally Advanced Esophageal Cancer Treated with Neoadjuvant Chemotherapy: a Propensity Score-Matched Analysis.
Sugimura K, Miyata H, Kanemura T, Takeoka T, Sugase T, Masuzawa T, Katsuyama S, Motoori M, Takeda Y, Murata K, Yano M. Sugimura K, et al. Among authors: takeoka t. J Gastrointest Surg. 2023 Jun;27(6):1055-1065. doi: 10.1007/s11605-023-05615-x. Epub 2023 Feb 7. J Gastrointest Surg. 2023. PMID: 36749557
Clinical Impact of Metastatic Lymph Node Size on Therapeutic Effect and Prognosis in Patients with Esophageal Squamous Cell Carcinoma Who Underwent Preoperative Chemotherapy Followed by Esophagectomy.
Sugimura K, Miyata H, Kanemura T, Takeoka T, Sugase T, Yamamoto M, Shinnno N, Hara H, Omori T, Motoori M, Ohue M, Yano M. Sugimura K, et al. Among authors: takeoka t. Ann Surg Oncol. 2023 Jul;30(7):4193-4202. doi: 10.1245/s10434-023-13393-8. Epub 2023 Apr 3. Ann Surg Oncol. 2023. PMID: 37010661
ASO Author Reflections: Clinical Impact of Metastatic Lymph Node Size on Therapeutic Effect and Prognosis in Patients with Esophageal Squamous Cell Carcinoma Who Underwent Preoperative Chemotherapy Followed by Esophagectomy.
Sugimura K, Miyata H, Kanemura T, Takeoka T, Sugase T, Yamamoto M, Shinnno N, Hara H, Omori T, Motoori M, Ohue M, Yano M. Sugimura K, et al. Among authors: takeoka t. Ann Surg Oncol. 2023 Jul;30(7):4203-4204. doi: 10.1245/s10434-023-13456-w. Epub 2023 Apr 8. Ann Surg Oncol. 2023. PMID: 37029864 No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 37118613
143 results